Advances in liver surgery enable the prospect of curative treatment for more patients

Although many prognostic factors predicting survival and cancer recurrence in patients undergoing surgery for colorectal liver metastases are already identified, the effects of newly introduced technologies and new drugs in the treatment of these patients are still poorly studied because of the presence of many involved factors.

If you want to include this story in your blog, copy and paste this formatted text: